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Abstract 
Clinical and basic research in the field of uro-
lithiasis has developed rapidly in recent years. Progress 
in extracorporeal shock wave lithotripsy (ESWL) and 
percutaneous nephrolithotomy (PNL) has brought about 
a revolution in the surgical treatment of urolithiasis and 
research at the cellular and molecular level is now ex-
panding. In spite of these advances, however, clinical 
treatment of urolithiasis remains far from satisfactory. 
Stone recurrence in many patients cannot be predicted 
and is beyond control of urologists mainly because the 
mechanisms of stone formation are still not fully under-
stood. It is necessary to study the process of stone-
formation more intensely at the cellular and molecular 
level, and to strengthen the links between basic and 
clinical research in the field. 
In this review, the processes involved in the for-
mation of stones are compared with those involved in 
normal bio-mineralization and a model of urolithiasis is 
put forward based on modern systems science. Attention 
is concentrated on: (a) Directions of research based on 
physico-chemical theories of stone formation; (b) The 
role of renal tubular defects in urolithiasis; (c) The 
role of free radical reactions in stone formation; and 
(d) Macromolecular abnormalities and their correction. 
Key Words: Urolithiasis, bio-mineralization, non-equi-
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Introduction 
Although there has been considerable progress in 
the field of urolithiasis research during the last decade, 
the precise mechanism of stone formation is still ob-
scure. It is necessary, therefore, to re-investigate the 
processes of stone-formation at the cellular and molecu-
lar level. Within the same time scale, rapid develop-
ments have taken place in systems science. These devel-
opments have to be incorporated in the model of stone-
formation. In this review, new concepts in stone 
research, such as systems science, will be introduced. 
Bio-mineralization and urolithiasis 
The concept that "urolithiasis can be considered 
as a syndrome that is related to pathological bio-mineral-
ization" has generally been accepted [80]. Bio-minerali-
zation is the process that occurs in the body and results 
in formation of bio-minerals. Because bio-minerals can 
only be formed under physiological conditions, some 
highly ordered structures and special means of organiza-
tion are essential. Bio-mineralization is associated with 
a series of specific properties and physiological func-
tions (Table 1). 
Bio-mineralization can be divided into two types: 
(a) physiological mineralization (e.g., normally 
growing bone, teeth and other hard tissues), and 
(b) pathological mineralization. 
There is a striking similarity in the chemistry be-
tween the two types of mineralization. The differences 
between them lie in the sites where the processes take 
place and in the degree of organization of the mineral 
concerned. Various types of pathological mineralization 
are listed in Table 2. 
Demineralization is the opposite process to miner-
alization. From the viewpoint of chemistry, both miner-
alization and demineralization can occur simultaneously 
and depend upon each other. From the viewpoint of 
biology, mineralization and demineralization are both 
"controlled" by cells. In this context, these are two as-
pects to "control": (1) the rate of the chemical reaction 
is controlled by various kinetic factors, and (2) the equi-
librium between mineralization and demineralization is 
controlled by thermodynamic factors. 
The introduction of the concept of bio-mineraliza-
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tion into the field of urolithiasis has necessitated taking 
into account the following: the cellular metabolism, cel-
lular activity, and the participation of macromolecules 
and matrix in stone-formation. Cells are considered to 
provide the required micro-environment and control for 
conditions necessary for mineralization, including syn-
thesis and regulation of macromolecules and matrix 
materials. Recently, Coe et al. [29) listed common 
protein inhibitors of crystallization in various vertebrates 
(Table 3). The authors proposed the idea that the prob-
lem of crystallization and its modulation by inhibitors 
has been a general problem for nature throughout evolu-
tion. Therefore, the concept of bio-mineralization could 
be useful in increasing our understanding of the mecha-
nisms of stone-formation. 
Modern systems science in urolithiasis 
The concept of "strong inference" as a strategy in 
science was first introduced into stone research by 
Finlayson [22]. To understand the mechanisms of stone-
formation at the cellular and molecular level, it is neces-
sary to introduce various elements of modern systems 
science, namely: (1) system theory, (2) cybernetics, 
(3) information theory, (4) bio-self-organization, and 
(S) non-equilibrium thermodynamics. 
First, we would like to give a brief introduction 
of several elements of system science; second, we will 
try to establish a link between systems science and the 
pathological process of urolithiasis; last, we will explain 
the mechanisms of stone-formation based on systems 
science. 
System theory. The human body may be consid-
ered to be a large system composed of many sub-systems 
in which many complex reactions occur simultaneously 
and depend on each other. Its main feature is that it 
comprises an open reactive system that has to exchange 
materials and energy between each sub-system and its 
surrounding environment. Compartmentalization of the 
human body includes a series of reactions which are 
demonstrated in physiological and biochemical processes 
as follows: (a) concentration of materials; (b) separation 
of reactants; (c) changes in various equilibrium points 
which depend on the concentration gradient of reactants 
and other conditions; (d) changes in reaction velocity. 
Cybernetics. In cybernetics, the relationship 
between input and output, and various modulations of 
these processes within a given system, are studied. The 
majority of chemical reactions in the human body are 
carried out under far from equilibrium conditions. A 
steady-state is established when input becomes equal to 
output. However, the system must be controlled in or-
der to establish homeostasis. Modulation of these sys-
tems usually depends on a pair of antagonistic regulators 
(promotory and inhibitory factors) or on an opposite di-
rection for a process (change-over switch). It should be 
emphasized that a non-equilibrium state can produce or-
derly structures in time (chemical vibration) and in space 
(dissipation structure and other sequence structures) 
[90). 
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Table 1. The characteristics of bio-mineralization. 
Structure High level of order in bio-minerals 
Composition Bio-minerals are formed in special media 
and are embedded in an organic matrix. 
Functions The constituent ions of all bio-minerals 
participate not only in the processes of 
mineralization and demineralization, but 
also in various cellular reactions. Bio-
minerals can only be formed during bio-
logical metabolism. 
Information theory. Information can be defined 
as a state and style of movement of an event. Informa-
tion processing has to be controlled, irrespective of 
whether it happens between a human being and its natu-
ral environment or between cells and their surrounding 
micro-environment. The process of transforming infor-
mation has a material base such as a message carrier, 
transmission media, and receptors, etc. There is a rela-
tionship between the sequence of events and the informa-
tion capacity: the larger the information content, the 
higher the sequence. For example, the selectivity of an 
enzyme for its substrate depends upon the size of the 
molecule and its spatial configuration, the distribution of 
the electron charge and its hydrophobic parameters. The 
more specific an enzyme, the larger its information con-
tent. It should be emphasized that modulation of homeo-
stasis can only be obtained when based on a highly or-
dered structure in the body, and that this modulation 
possesses a material base. 
Bio-self-organization. Bio-self-organization is 
the basis of the maintenance of biological systems. 
Many human organs, tissues and cells exhibit this phe-
nomenon, which guarantees the stability of each biologi-
cal entity. Bio-self-organization is the process of form-
ing an orderly structure. This can be considered to be 
a very important characteristic of the biological 
universe. 
Non-equilibrium thermodynamics. The human 
body can be thought of as a highly ordered structure be-
ing at a far from equilibrium state. Between this open 
reactive system and its surrounding environment, ex-
change takes place, not only of materials, but also of en-
ergy. Non-equilibrium thermodynamics studies the ther-
modynamic behaviour taking place tinder far from equi-
librium conditions which can lead to the formation of a 
dissipative structure that is stable, orderly and dynamic. 
This occurs under the following conditions: (1) the sys-
tem must be an open reactive system; (2) various ele-
ments within the system should have non-linear correla-
tions; (3) when the system becomes unbalanced, a new 
stable structure with orderly characteristics is formed 
through fluctuations of the system. It should be noted 
that the dissipative structure is a living structure which 
is quite different from an equilibrium death structure. 
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Table 2. Various pathological bio-mineralization processes. 
Tissue mineralization Calculus 
(1) Calcification of necrotic tissue 
(2) Ectopic mineralization 
(1) Dental calculi 
(3) Crystal membranolysis 
(2) Gallstone, gastric and pancreatic calculi 
(3) Renal, ureteral and bladder calculi 
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Figure 1. A response model of stone formation in the 
urinary tract system in which I: = set of input signals; 
Q = set of metabolic states; 0 = set of output signals; 
F = state transition function; and G = output state func-
tion. According to this model, an abnormal output sig-
nal or state function demonstrated by an individual stone 
former can be imagined from his initial metabolic state 
of body and input signals from its surrounding environ-
ment. See text for details. 
The modern concept of systems science can be in-
cluded in our thinking about urolithiasis, in relation to 
its initiation, progress, treatment and prevention. We 
can use systems science to answer the question: why do 
some people suffer from urolithiasis while others, living 
under the same conditions, do not? 
Urolithiasis can be considered to result from an 
alteration in the state functions. There is a set of state 
functions representing a set of "n" metabolic states (Q) 
in the urinary tract system which can be described by 
Q = I q1,q2,q3, ... ,q 0 I - Thissystemcanrecognizeand 
interact with a set of "m" input signals (I:) originating 
from its environment which can be described by 
















set of "p" output signals (8) that can be described by 
8 = I 8 1,8 2,8 3, ... ,8P I . Assuming that there is a 
transition within the system from one internal state to 
another, following a given input signal, the reaction 
proceeds according to a set of well-defined rules: 
F:QxI:-+Q (I) 
where "x" indicates interaction, and F is a transition 
function or a set of rules that pairs each member of set 
Q x I: with one or more members of set Q. The system 
generates an output signal whose character is determined 
by its internal state according to the rule: 
G:QxI:-+8 (2) 
where G is the output function that pairs the internal 
states plus received signals of the system with an output 
signal. Above statements are schematically shown in 
Fig. 1. It can be seen that the abnormal output signals 
(8) (e.g., lower urinary inhibitory activity, hypercalci-
uria, hyperoxaluria, hyperuricosuria and hypocitraturia) 
and the abnormal output state function (G) as revealed 
by a dynamic procedure such as a calcium load test, in-
dicate that there may be something wrong with the func-
tion of the urinary tract system (Q), and/or that the sys-
tem cannot tolerate a strong stimulation of environment 
factors (I:). 
The application of systems science to stone-
formation is summarized schematically in Fig. 2. Gen-
erally speaking, an input signal must be recognized first, 
then the body can trigger the control-unit for response. 
Thus, the body can remain in homeostasis during normal 
physiological processes. Homeostasis in human body 
represents a metabolic state with a very low probability 
value for stone-formation. 
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Figure 2. General pathological model of urolithiasis 
deduced by system science. From the viewpoint of sys-
tem science, urolithiasis can be thought of as a kind of 
disorder of regulation occurring between human body 
and its surrounding environment. Homeostasis repre-
sents a normal physiological regulation state which can 
tolerate triggering factors from the environment and re-
main unchanged. Once the homeostasis is interfered 
with too strong triggering factors, human body is under-
going a over-control regulation resulting in "injuries" or 
dysfunction. If the injuries cannot be repaired by the 
system (human body), the pathological process of stone 
formation will start. See text for details. 
It should be emphasized that no "injury" to the 
system occurs during normal physiological processes. 
If there is mild "injury", it can be repaired by the body 
itself. Once this regulatory repair ceases to function 
properly, however, a persistent "injury" will take place. 
When the injury cannot be repaired, the human body 
system will enter into the pathological process known as 
urolithiasis. 
Unfortunately, in only approximately 20% of pa-
tients with calcium urolithiasis, an underlying metabolic 
disorder or molecular defect can be diagnosed. For the 
remaining 80% of the patients, they may have multiple 
abnormalities including idiopathic hypercalciuria, hyper-
uricosuria, mild hyperoxaluria, and hypocitraturia which 
often may be present with significant overlap of risk fac-
tors [113]. In these cases, a renal cellular defect in the 
handling of calcium, uric acid, oxalate, and citrate 
should be considered as possibly being responsible. 
Normal subjects have a "perfect" bio-control 
system. For example, crystal nucleation, which occurs 
in highly supersaturated urine, seems to be a normal re-
sponse of the body to an excess of solutes in urine. 
Once a large amount of crystals precipitates in urine, 
supersaturation decreases immediately. The speculation 
that the nucleation rate, in up to 92 % fresh urines from 
normal subjects, was higher than those from stone-for-
mers, has recently been confirmed by Kavanagh [57] us-
ing a continuous crystallization system. This may ex-
plain why crystals can often be found in urines from nor-
mal subjects. The differences between urinary crystals 
of stone-formers and normal subjects in size, composi-
tion and surface properties can be related to the proc-
esses of their formation in vivo. Unfortunately, we still 
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do not know where the initial site of formation of the 
urinary crystals is: in urine itself, within the renal 
tubular lumen or within renal tubular cells? 
It has been demonstrated that a high percentage of 
large crystals ( > 12 1-'m) is one of the characteristics of 
recurrent Ca Ox urolithiasis [99]. The lack of an appro-
priate reaction against exogenous disturbances, such as 
overloads of calcium, oxalate, acid, citrate, purine, and 
protein, in stone-formers suggests defects in their con-
trol system in vivo [38, 52, 61, 62, 86, 105, 106]. An 
epidemiological investigation has shown that stone-for-
mers have a metabolic sensitivity to stimulation by the 
diet [99]. This aspect of a body process "out of control" 
may explain the existence of "injuries" to the urinary 
tract. An "injury" to the organism can arise both at the 
cellular and molecular levels. The same triggering fac-
tor may induce different pathological processes, depend-
ing on which sites and which target molecules are affect-
ed. Many abnormal phenomena, which are found in 
stone formers, e.g., pathological alteration of renal 
tubular cells, formation of Randall's plaques, alteration 
of the properties of the urothelium, and the secretion of 
abnormal macromolecular substances, might be attribut-
ed to the existence of injury to the renal epithelium. 
According to the analysis of pathological process-
es of urolithiasis from the viewpoint of modern systems 
science (see Figs. 1-2), it is easy to understand the di-
rections for future research as proposed by the Consen-
sus Development Conference on the Prevention and 
Treatment of Kidney Stone [32]. Based on these 
directions, the following questions should be addressed: 
(a) What are the triggering factors which induce 
stone-formation? 
(b) How do these factors play a role in stone-
formation? 
(c) Where are the injuries located at the various 
levels associated with stone formation? What is the mo-
lecular basis of injury? 
(d) Can we recognize and correct the molecular 
and cellular abnormalities to prevent stone formation and 
its recurrence? 
Recently, evidence has indicated that the early 
events in the process of stone-formation occur in the 
kidney. These include: 
(a) Sites of initial stone/crystal formation and 
their micro-environment [36]; 
(b) Injury of renal tubules and crystallization 
occurring afterwards [60, 69]; 
(c) Abnormal properties of intrarenal macromo-
lecular inhibitors and stone formation [ 4, 6, 29, 30, 37, 
50, 116, 117]; 
(d) Abnormal transport of calcium and oxalate in 
kidney tubular cells and its influence on stone-formation 
[12, 21, 55, 72, 74]; 
(e) Interaction between crystals and cells, and the 
mechanisms of crystal retention, especially investigation 
of the principle of cellular modulation in stone-formation 
[ 120]; 
New concepts in renal stone research 
(f) Effects of free-radical reactions occurring in 
vivo on stone formation [94, 109-111, 118]. 
Physico-Chemical Theory of Stone Research 
The physico-chemical theory of stone research has 
given the exact definition of the phases of stone-forma-
tion and has indicated the targets for the prevention of 
stone formation and stone recurrence [40, 81, 85, 96]. 
In the past, it has been shown that many factors can play 
a role in stone-formation by the means of thermodynam-
ic and kinetic processes. Therefore, new data have to be 
linked with this physico-chemical theory. However, to 
explain the complex situation which exists in vivo, the 
physico-chemical theory of stone formation needs to be 
developed in two new directions: 
(a) from the use of simple media (artificial or 
diluted urine) to complex physiological media (whole 
urine system, intracellular and extracellular fluid, and 
bio-membranes); and 
(b) from classical thermodynamics in a closed 
system to non-equilibrium thermodynamics in an open 
reactive system. 
It may be necessary to explain why there should 
be a development from the use of classical thermody-
namics to non-equilibrium thermodynamics. This is log-
ical, because stone-formation is the process of forming 
bio-minerals, occurring under "far-from-equilibrium" 
conditions in the body which itself is an open system. 
Hence, application of non-equilibrium thermodynamics 
in life sciences becomes more and more important. 
Until now, no one has been able to produce in 
vitro bio-minerals such as bone, teeth and renal stones, 
that possess exactly the same features as their counter-
parts in vivo, in terms of composition and structure. A 
satisfactory explanation of the fine structure of the bio-
minerals can be made utilizing non-equilibrium thermo-
dynamics, because a stable, orderly and dynamic struc-
ture can only arise by non-linear rising and falling in an 
open system. 
According to Prigogine's theory [82] of dissipa-
tive structure, the change of entropy (dS) in an open sys-
tem can be divided into the following two parts: 
(a) the change of entropy production (dSi) is due 
to an irreversible process inside the system (e.g., heat 
transfer, diffusion, chemical reaction etc.); and 
(b) the change of entropy current (dSe) is due to 
the exchange of materials and energy with the environ-
ment, that surrounds the system; 
The total entropy change (dS) in the system is the 
sum of dSi and dSe described as equation (3): 
(3) 
From the second law of thermodynamics we have, 
for a non-equilibrium state: 
(4) 
but the value of dSe can be positive or negative, there-
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fore, the change of entropy (dS) in the system will be 
positive or negative depending on the value of dSe. 
When dS is negative the total entropy of the system will 
decrease with decreasing value of negative entropy cur-
rent (dSe) and the system may constitute a dissipative 
structure in which the system is transformed from a ran-
dom to a non-random one, and form a high ordered 
structure with low entropy. 
The concept that a non-equilibrium state is the 
origin of the sequence, has been recently recognized and 
accepted [82, 83]. Some questions previously assumed 
to be insoluble in the field of life sciences, such as bio-
logical evolution, self-catalysis, bio-self organization, 
negative and positive feedback control (which cannot be 
solved by classical thermodynamics) have been success-
fully explained [56]. 
To define the processes of stone-formation at the 
molecular and cellular levels, it is essential to have a 
model available. An attempt to incorporate the effects 
of secretion, re-absorption and flow in the urinary tract 
in a highly integrated computer-simulation strategy has 
recently been published [22]. A molecular model of the 
living cell, developed during Bhopalator (India) congress 
in 1985, integrates molecular genetics, enzymology and 
biochemistry within a coherent theoretical framework 
[56]. It can be supposed that the Bhopalator cell model 
may be useful for the later investigation of stone-forma-
tion. According to the Bhopalator model, the living cell 
has to be considered as a self-moving, self-regulating 
and self-reproducing machine that receives information 
and energy from its environment, processes the informa-
tion and generates output signals to the environment in 
order to realize a teleonomically designed function [56]. 
Traditionally, one thinks that stones can be 
formed in urine with high supersaturation and low inhib-
itory activity [97]. This speculation perhaps is partially 
right, but the initial micro-environment might need a 
special reaction medium and a matrix, and the influence 
of a cellular metabolism. This environment is generally 
ignored. For instance, it has been suggested that miner-
als and organic matrixes are both necessary for the 
orderly structure observed in urinary calculi. However, 
the following questions remain to be answered: 
(a) Which component plays the decisive role in 
stone formation: the minerals or the organic matrix? 
(b) What is the ordering structure of a stone? 
(c) How do the minerals and matrix cling 
together? 
It is necessary to study the mechanisms of stone 
formation not only in simple inorganic solutions, but 
also in complex physiological media such as whole 
urine, cytosol and tissue fluid [91, 104]. In addition, 
there is now more emphasis on the role played by tubu-
lar cells in stone-formation. There are several possible 
roles: 
(a) Cellular compartmentalization may provide 
the required micro-environment for bio-mineralization; 
(b) Cells may induce crystal nucleation on a 
template by supplying growth sites for crystallization 
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and by inhibiting crystal growth and aggregation by 
secreting and regulating macromolecular substances and 
matrix materials; 
(c) Cells may create, through their metabolic 
activity, the conditions that allow bio-mineralization to 
take place in the cell-surroundings. 
Renal Tubular Defects and Urolithiasis 
The mechanism by which the initiation of calcium 
oxalate stone occurs is not completely understood. 
There are two main theories. One theory states that 
stone-formation is essentially an extracellular process. 
When the renal tubular concentrations of calcium and 
oxalate exceed the formation product of that salt, it 
causes spontaneous crystallization of calcium oxalate 
within the renal tubule. If within the transit time of 
urine through the urinary tract, the resulting crystals and 
aggregates grow sufficiently iarge to become trapped at 
some narrow section of the tract, they may go on to 
form stones [ 100]. The other theory states that it is an 
intracellular process. Crystals are formed first within 
the tubular cells and, if this is excessive, it leads to cell 
death. The crystals and cell debris extruded from the 
cell act as nuclei for renal stone-formation by blocking 
the tubule [93]. Whichever theory is correct, the con-
cept that a cellular metabolic defect in the handling of 
inorganic ions and/or at in the synthesis of macromolec-
ular substances is the basic problem in stone-formation 
has generally been accepted [21, 30, 68]. The specula-
tion that renal tubular injury induced by various agents 
is the cause of urolithiasis has been supported by animal 
investigation [19, 60), cell culture study [69] and 
clinical observation [I I]. 
Calcium oxalate stones can be induced in animals 
by the oral administration or injection of oxalate or one 
of its precursors, with or without gentamicin, have been 
indicated. In such models, renal tubular injury has been 
detected [27, 58-60). The enhanced excretion of urinary 
enzymes, including brush border enzymes (such as alka-
line phosphatase, ,,-glutamyl transpeptidase and leucine 
aminopeptidase) and lysosomal enzymes (such as N-ace-
tyl-ll-glucosaminidase) during the first 24 hours of chal-
lenge, suggests that there may be damage to the brush 
border membrane of the renal tubules and that this corre-
lates with the retention and deposition of crystals in the 
kidney [60), Ultrastructural studies have also demon-
strated a relationship between crystal deposition and 
damage to the tubular epithelium. Crystal deposits, 
formed as a result of hyperoxaluria, have always been 
associated with degradation of the cell membrane. But 
in these animal experiments, the following two questions 
were not answered: 
(a) Does the renal tubular injury precede or 
follow the process of crystal formation? 
(b) Is the initial crystal formation an intracellular 
or an extracellular process? 
Deganello et al. [36) reported that, according to 
their micropuncture data, the tubular fluid in the thin 
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segment of the Renie's loop is the initial site of stone-
formation. Recently, our ultrastructural study of experi-
mentally induced microliths in rat was able to demon-
strate not only ultrastructural changes in the proximal 
tubular cell, but also showed the presence of intracellu-
lar crystals in more distal tubular cells, after 4 to 8 days 
on the lithogenic diet [19). 
It is known that a specific metabolic disorder can-
not be found in 80 % of patients with idiopathic calcium 
oxalate urolithiasis (ICU). It is not yet clear as to 
whether ICU is a specific disease or whether it is only 
the expression of an intrinsic metabolic abnormality, and 
is ICU a disease of renal cells or does it originate in the 
urine? Should we switch our research efforts to the biol-
ogy of tubular cells, or should we continue to address 
the traditional stone-forming constituents of urine and 
their physico-chemistry in order to understand the early 
events of stone disease [107]? In this connection, the 
following questions need to be answered [32]: 
(a) What are the fundamental mechanisms of 
ICU? 
(b) Is renal tubular injury and/or dysfunction 
involved in the pathogenesis of stones? 
(c) Is there a genetic basis for ICU and can 
individuals at risk of stones be identified using genetic 
probes? 
(d) For defined genetic disorders will gene 
therapy have practical application? 
In this connection, Bianchi et al. [17] found that 
in erythrocyte membranes the calcium-magnesium-
ATPase activity was significantly increased in 38 pa-
tients with idiopathic hypercalciuria. They suggested 
that the abnormalities in erythrocyte calcium-magnesi-
um-ATPase activity may represent an inherited defect in 
calcium transport related to the cause of idiopathic 
hypercalciuria. 
Baggio et al. [11, 12] reported altered red blood 
cell transmembrane transport of oxalate in "idiopathic" 
renal stone formers, they found a higher-than-normal ex-
change rate in 78 % of patients. This observation has 
since been confirmed by other groups [55, 74). How-
ever, Motola et al. [72] have recently shown that the ab-
normal values of oxalate self-exchange in erythrocytes 
is not specific to patients with ICU but may be found in 
patients with other renal diseases. However, Baggio in-
sists that Motola's observation does support his 
hypothesis [ 43). 
The defect in oxalate self-exchange in erythro-
cytes of patients with idiopathic calcium oxalate nephro-
lithiasis seems to lie in a Band 3 protein that controls 
anion transport by phosphorylation and dephosphoryla-
tion [13, 14). Recently, Baggio et al. [15] reported that 
oral administration of glycosaminoglycans (GAGs) sig-
nificantly lowered both the rates of Band-3 phosphoryla-
tion and erythrocyte oxalate self-exchange, and reduced 
urinary oxalate in 40 patients with idiopathic calcium-
oxalate nephrolithiasis. The mechanism of action of 
GAGs in correcting the abnormality in the erythrocytes 
of patients with ICU seems to be through the inhibition 
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of the protein kinase involved in Band-3 phosphoryla-
tion. This, in turn, leads to a lower transmembrane 
oxalate transport. 
Since red blood cells are good models for the 
study of membrane function and transport systems, the 
above results obtained from red blood cells could logi-
cally be extrapolated to other types of cells. If intestinal 
absorption and renal oxalate secretion occur in a fashion 
similar to that in red blood cells (via Band-3 or Band-3-
related proteins) then the relationship between the com-
mon cellular defect and the pathophysiology of idio-
pathic calcium oxalate nephrolithiasis may be defined. 
New molecular and biological investigations in the field 
of Band-3 protein and anion transporters will have to be 
carried out in order to test the hypothesis that an inherit-
ed defect in the cellular transport of oxalate may be a 
common factor in idiopathic calcium oxalate nephro-
lithiasis [21]. In order to elucidate the cellular 
mechanisms underlying the cause of stone disease, 
Sigmon et al. [114] studied oxalate uptake in suspen-
sions of renal cortical and papillary cells derived from 
control and stone-forming rats. They found that, in the 
renal tubular cells from rats, in which stones were in-
duced by administration of ammonium oxalate and genta-
micin, there was reduced uptake of oxalate in cortical 
cells and an enhanced uptake of oxalate in papillary cells 
compared with the corresponding cells from untreated 
control rats. This finding suggests that the alteration of 
oxalate transport in damaged rat renal tubular cells may 
play a role in the causation of their stones. 
In summary, up to now, the fundamental mecha-
nisms of ICU are not yet solved. Although it is not 
clear yet whether or not there is a common defect in cel-
lular calcium and/or oxalate transport in the patients 
with ICU, further investigations of searching for any 
possible genetic abnormality in these patients probably 
are needed. 
Free Radical Reaction in Stone Research 
A marked increase in interest in the role of free 
radicals in biology and medicine has developed during 
the last 20 years [42, 47]. (A free radical is an atom or 
molecule with one or more unpaired electrons in the 
outer orbit such as -0 2-, and ·OH). Many free 
radicals can be detected using an electron paramagnetic 
resonance spectrum analyzer. 
A multitude of endogenous and exogenous sources 
of free radicals exist. Exogenous sources include oxida-
tive drugs (such as CCl 4 and acetaminophen), cigarette 
smoke, radiation and substances that oxidize glutathione. 
Considering the situation in vivo, cellular sources in-
clude the mitochondrial electron transport chain, the mi-
crosomal electron transport chain, oxidation enzymes 
(such as xanthine oxidase and cyclooxygenase), phago-
cytes, and cellular auto-oxidation of Fe2 + and epi-
nephrine [42]. 
In general, in a free radical reaction, the follow-
ing three steps are present: induction ➔ propagation ➔ 
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termination. Once a free radical reaction is induced in 
cells, the reaction is not only fast, but it may also seri-
ously damage cells. For example, lipid peroxidation oc-
curring on the cellular membrane may disrupt the struc-
tural integrity of the lipid bilayer leading to increased 
membrane permeability and subsequent impaired ion 
transport, impaired electron transport for the oxidative 
phosphorylation in mitochondria, and increased lyso-
somal permeability. Increased lysosomal permeability 
causes the release of hydrolytic enzymes that further 
enhance cell injury [44]. 
Recent evidence indicates that an oxygen and/or 
hydroxyl radical reaction mechanism can injure renal tu-
bular cells and promote calcium oxalate crystallization 
within the cells [94]. Bakris et al. [16] reported that the 
increase in urinary Tamm-Horsfall protein excretion af-
ter injection of contrast medium is, in part, mediated by 
oxygen free radicals and may serve as a marker of renal 
tubular injury. Walker and Shah found evidence for a 
role of hydroxyl radical in gentamicin-induced acute 
renal failure in rats [121]. Selvam and Kurien [109] 
reported that oxalate can induce lipid peroxidation 
through inhibition of catalase activity. 
Lipid peroxidation of unsaturated fatty acids has 
been linked with altered membrane structure and enzyme 
inactivation which may lead to an oxidative cellular 
damage [39]. Although it was known that deficiency of 
vitamin B-6 results in increased oxalic acid biosynthesis 
in liver and leads to hyperoxaluria, very little work has 
been done on the implications of the hyperoxaluria in-
duced by vitamin B-6 on lipid peroxidation in subcellular 
fraction of the rat kidney. Recently, the results pre-
sented by Ravichandran and Selvam [94] indicated that 
calcium and oxalate accumulate predominantly in the 
subcellular fraction of the kidney, and that these mem-
branes-like materials may be the site for stone-formation 
through peroxidative damage. 
More recently Selvam and Devaraj [110] have ex-
amined the effect of lipid peroxidation on oxalate bind-
ing in mitochondria. Their finding is that lipid peroxi-
dation, via the hydroxyl radical reaction, led to oxalate 
binding in rat kidney mitochondria. Therefore, it can be 
reasoned that the accumulated oxalate, derived from the 
enhanced oxalate binding reaction under the condition of 
increased peroxidase activity, may be an important fac-
tor for the aetiology of stone formation. 
Erythrocyte lipid peroxidation has been found to 
be elevated in kidney stone patients [3]. Taking into ac-
count the fact that the flux rate of erythrocyte oxalate 
self-exchange is abnormally high in the patients with 
idiopathic urolithiasis [10], one may speculate that the 
elevated lipid peroxidation, resulting in injury of the 
membrane, may be responsible for this finding. 
Increasing evidence regarding the role of free rad-
ical reactions in the causation of stone-formation sug-
gests that the effects of free radical reactions on oxalate 
binding, on macromolecular substances secretion and on 
the oxalate transport should be explored in model sys-
tems, both in vitro and in vivo. A new investigation of 
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Table 4. Various macromolecular abnormalities in urolithiasis. 





Ribose phosphate pyrophosphokinase 
Hypoxanthine phosphoribosyl transferase 










Urolithiasis (Uric acid) 





Glycosaminoglycans Heparan sulphate and 
Chondroitin sulphate 
Deficiency or abnormal structure 
Abnormal existing state 
Deficiency, Structure 
CGI and CAI** 
CGI and CAI 
CGI and CAI; anti-
adherence of crystals and Composition 
Ribonucleic acid (RNA) Deficiency or others CGI and CAI 
Uropontin Unknown CGI and CAI 
Crystal matrix protein 
Inter-a-trypsin protein 
Unknown CGI and CAI 
Unknown CGI and CAI 
Water surrounding macromolecules in kidney Abnormal structure or composition CGI and CAI 
Anion exchanger 
Band-3 protein Structure Oxalate transport 
*The abnormalities of enzyme, inhibitors and anion exchanger reflect metabolic disorders and cellular injuries or dys-
functions in patients with urolithiasis. 
**cGI: inhibition of crystal growth; CAI: Inhibition of crystal aggregation. 
the mechanisms of a free radical reaction in stone forma-
tion [111] and an application of a free radical scavenger 
such as DL a-lipoic acid in stone prevention has more 
recently been reported [118]. 
Macromolecular Abnormalities and 
Their Correction in Urolithiasis 
Recently, investigators have concentrated on try-
ing to determine the macromolecular abnormalities asso-
ciated with urolithiasis and on looking for approaches to 
correct them. Modern molecular biological techniques 
are available to clarify the relationship between abnor-
mal macromolecular substances and stone formation. 
Probably gene therapy of stone disease can be expected 
in the future. Various macromolecular abnormalities in 
urolithiasis are summarized in Table 4. Because the 
listed molecular pathophysiological mechanisms of the 
enzyme disorders have been clarified, here we will only 
discuss the following abnormalities of macromolecules: 
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Nephrocalcin 
Nephrocalcin is a glycoprotein isolated and puri-
fied by Nakagawa et al. [75, 79]. The nephrocalcin in 
urine is a macromolecular complex with molecular 
weight (MW) from 14 to above 200 kD. Cell culture 
and immunohistochemical examination have indicated 
that nephrocalcin is present in renal proximal tubular 
cells and in the thick ascending limb of Henle's loop 
(TAL) [76, 115]. 
It is well known that normal nephrocalcin not only 
inhibits the growth of calcium oxalate crystals, but also 
the aggregation of such crystals which is a most impor-
tant risk factor for stone-formation [48, 78, 125]. 
Nephrocalcin can be adsorbed to calcium oxalate crystals 
forming a monomolecular layer which inhibits crystal 
growth. As nephrocalcin is a metabolic product of renal 
cells, defects in the molecular structure of nephrocalcin 
and a pathophysiological disorder may be responsible for 
stone formation. An investigation of the interaction 
between a cultured cell line of monkey kidney cells and 
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calcium oxalate monohydrate (COM) crystals has been 
done by Lieske et al. [65] who found evidence that 
nephrocalcin can block the initiated DNA synthesis 
induced by COM crystals stimulation. 
Patients who form kidney stones, are claimed to 
produce an abnormal nephrocalcin with a very weak in-
hibitory activity towards calcium oxalate crystallization 
[77]. The main molecular abnormality of nephrocalcin 
from patients with calcium oxalate nephrolithiasis is said 
to be a deficiency in -y-carboxyglutamic acid (Gla). Be-
cause Gia in nephrocalcin commonly stabilizes molecules 
into their final configurations through calcium bridges, 
loss of Gla leads to reduction of inhibitory activity of 
nephrocalcin and to loss of its amphilicity [77, 78]. 
However, later data do not support the finding [Netzer 
et al. (1992) and Hughes et al. (1992); abstracts at the 
VIIth International Symposium on Urolithiasis, Cairns]. 
Recently some new non-nephrocalcin inhibitors of 
crystallization including uropontin [116], crystal matrix 
protein (CMP) [37], Inter-a-trypsin protein [117], and 
an other, unnamed, glycoprotein [4] have been demon-
strated. These inhibitors are listed in Table 4. 
Tamm-Horsfall protein/Uromodulin 
Tamm-Horsfall protein (THP) isolated from hu-
man urine by salt precipitation method [119] and uro-
modulin isolated from urine of pregnant women by lectin 
adherence columns [73] are the most abundant proteins 
in normal human urine, although THP and uromodulin 
may be different names for the same protein since the 
sequence of cDNA and the amino acids of uromodulin 
has recently been shown to be identical to THP [53, 89]. 
The physico-chemical and biological properties of THP 
have been studied extensively, but its function in various 
pathological and physiological processes remains ob-
scure [54, 102]. Rindler et al. [95] have used cDNA en-
coding for THP/uromodulin to study the release of the 
expressed protein from cultured cells. Their results in-
dicate that THP is one member of lipid-like membrane 
proteins and is released into the urine after the loss of its 
hydrophobic anchor, probably by the action of a phos-
pholipase or a protease. Two excellent reviews have re-
cently been published on this topic: one provides back-
ground data on the synthesis of THP/uromodulin and on 
its location and properties [63], the second reviews the 
roles of THP in calcium oxalate monohydrate crystalliza-
tion [49]. 
THP/uromodulin is a major and specific renal 
glycoprotein which readily polymerizes to form a gel 
under conditions of low pH, high ionic strength and the 
presence of certain mono- and divalent ions. It is syn-
thesized by the kidney and localized in the epithelial 
cells of the thick ascending limb 2(T AL) of Henle' s loop 
and of early distal convoluted tubules [64, 112]. THP/ 
uromodulin is released into urine in large quantities in 
a polymeric form (MW = 7x10 7 Da). Nuclear magnetic 
resonance (NMR) data and available molecular 
biological evidence suggest the presence of a single THP 
gene and multiple lectin binding sites in the tetra-
antennary chain of THP, which further suggest that there 
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may be many immunomodulatory roles for THP [33, 53, 
123]. 
Based on THP/uromodulin synthesis, localization 
and molecular structure, this glycoprotein may play the 
following roles in calcium oxalate urolithiasis: 
(a) THP may be considered as a intranephronic 
inhibitor of crystal growth and agglomeration. It 
prevents large crystal formation under physiological 
conditions [30, 108]. 
(b) Specific intranephronal pathological condi-
tions, such as low pH, high ionic strength, high concen-
tration of sodium and calcium and presence of oxygen 
free radicals, can stimulate THP self-polymerization in 
tubules. As a result, THP may be considered as a pro-
moter of stone formation [103]. 
(c) According to the protective colloidal theory 
of stone formation [23], THP in normal urine could be 
bound to crystal surfaces as a stabilizing agent for the 
urinary colloidal system through a steric stabilization 
mechanism. Thus, THP can be considered as an inhibi-
tor of stone-formation. 
(d) Depending upon the urinary environment, 
THP in urine may exist in different forms. Non-poly-
merized THP can be considered as an inhibitor of crys-
tallization; whereas polymerized THP is a promoter [18, 
108]. 
(e) Since mannose-sensitive fimbriated bacteria 
such as E. coli adhere to THP via mannose-containing 
side chains, it has been suggested that THP may trap uri-
nary pathogens and prevent them from cloning the uro-
thelium [84]. This mechanism ofTHP may be beneficial 
for the prevention of stone-formation and stone recur-
rence. 
(I) A free radical reaction may occur in the 
kidney to induce stone formation, in which intra-
nephronal THP could be polymerized and denatured in 
a very fast reaction [ 16]. 
Although many studies have been carried out on 
THP/uromodulin gene analysis, molecular structure 
analysis, immunological characterization and its corre-
sponding physiological functions, we still do not know 
what is the exact nature of THP from patients with calci-
um oxalate urolithiasis either in molecular structure of 
THP or in its function. It has been shown in several stu-
dies that THP from stone formers, at low pH in the pres-
ence of NaCl and calcium, exhibits an increased tenden-
cy towards self-aggregation which reduces its ability to 
interact with crystals and prevent their aggregation [18, 
50]. The tendency may be inheritable, but the molecular 
basis for the effect is unknown. Further investigation of 
the molecular defects in THP from patients with urolithi-
asis may be an important direction for stone research. 
Glycosaminoglycans 
Glycosaminoglycans 1 (GAGs) are polysaccharide 
1In literature, some confusion exits about GAGs and 
polysaccharides. Some semi-synthetic polysaccharides 
such as sodium petosan polysulphate are not real GAGs, 
they should be named sulphated polysaccharides. 
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chains composed of repeating disaccharides of identical 
composition. GAGs including heparan sulphate, chon-
droitin sulphate, dermatan sulphate and hyaluronic acid 
are naturally occurring in human urine. GAGs may be 
present in urine in a free form or in association with 
proteins, such as glycoproteins. Little is known about 
the mechanisms involved in the synthesis and excretion 
of GAGs in man. Although the differences of urinary 
GAGs in quality or quantity between patients with uro-
lithiasis and normals are not clear yet, there is no doubt 
that GAGs and a number of semi-synthetic sulphated 
polysaccharides can modulate calcium oxalate crystalli-
zation as is shown in various model systems in vitro and 
in vivo [26, 51]. The following mechanisms of action of 
GAGs in calcium oxalate stone prevention: 
(a) GA Gs can act as inhibitors of calcium oxalate 
crystal growth and aggregation in vitro [26, 34); 
(b) GAGs act as protectors of the urinary tract 
mucosa and can prevent crystal adherence to the mucosa 
[45, 88, 120]; 
(c) GAGs can correct oxalate transport disorders 
occurring at cellular membranes [15, 21]; 
(d) GAGs can modify the micro-environment 
within cells and in urine to prevent stone-formation [25]. 
It should be noted, however, from a recent study 
in rats that chondroitin sulphate promotes the growth of 
stones in the urinary tract [71]. This finding suggests 
that there is a complex situation in the mechanism of ac-
tion of both endogenous GA Gs and exogenous sulphated 
polysaccharides in stone formation. Investigations of the 
mechanisms by which GAGs prevent stone-formation 
should not be restricted to urines. The correlation be-
tween active stone formation and GAGs behaviour in cell 
should be an important project. Many receptors for sul-
phated polysaccharides (GAGs) on lymphocytes as well 
as on other cell types such as macrophages, polymer-
pronuclear leukocytes, mast cells and fibroblasts, have 
been demonstrated by Chong and Parish [28) and Parish 
and Snowder [87). Their studies illustrated that a varie-
ty of cell types and cell lines are able to bind certain 
sulphated GAGs selectively. Clearly, biochemical char-
acterization of these receptor molecules is important for 
a better understanding of the mechanisms of stone-for-
mation at the cellular level. 
Baggio et al. [15] found that GAGs inhibit the 
phosphorylation of Band-3 protein that may be responsi-
ble for oxalate transport. Oral GA Gs can correct the ab-
normality of red blood cell oxalate self-exchange rate 
and reduce urinary oxalate excretion in patients with 
idiopathic calcium nephrolithiasis. 
In spite of the possible protective effects of GA Gs 
against stone-formation shown in recent experimental re-
sults, the possible role for the accumulation of GA Gs in 
stone matrix has to be investigated. It is possible that 
molecular defects of GAGs caused by abnormal cellular 
metabolism, have some connection to stone formation. 
Water-surrounded macromolecules in kidney 
A new approach, at the molecular level, to the un-
derstanding of the processes of stone-formation is to iso-
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late the specific pathophysiological and biochemical 
characteristics of the stone forming environment [6-8). 
In these studies, proton-relaxation time measurements 
were performed on lyophilized urine samples collected 
from recurrent calcium oxalate stone formers (SF) and 
normal subjects (N). 1H- and 2H-nuclear relaxation times 
(T 1, T2) which change during rehydration of various 
lyophilized urines, were measured using NMR. The 
prolongation of the relaxation times as a function of 
rehydration was found to differ significantly between SF 
and N (P < 0.005). Water compartmentalization was 
calculated according to a fast proton diffusion model. 
Throughout most of the rehydration process, 
significantly less water (P < 0.001) was bound to the 
compounds of urine from SF than that obtained from 
normal subjects. These results suggest that the 
macromolecules in the urine of calcium oxalate stone-
formers and normals differ in their amount of water 
binding sites and in the water multilayer thickness 
surrounding them. Hydrophilic compounds, with a rela-
tively large active surface area, seem to be characteristic 
of the urine of normal individuals. Azoury's results [6-
8] obtained from Iyophilized urinary compounds by 
NMR are similar to those of Nakagawa et al. [78) who 
reported that an important feature of the nephrocalcin 
from patients with urolithiasis is the loss of its 
amphilicity, which indicates less separated and well-
organized hydrophilic and hydrophobic sites. 
Band-3 and related protein 
Increasing evidence indicates that a high concen-
tration of oxalate is a more important risk factor for 
stone-formation than hypercalciuria [41, IOI]. Williams 
and Wandzilak [124] reviewed the mechanisms involved 
in the synthesis, absorption, excretion, and transport of 
oxalate and the factors controlling these processes in 
man, and gave background data on the clinical syn-
dromes associated with hyperoxaluria and recurrent cal-
cium oxalate stone disease. 
In recent years, the possibility that some patients 
with urolithiasis have a generalized oxalate transport ab-
normality, has attracted the attention of investigators 
[11-15, 17, 21). Band-3 protein is a specific anion 
transporter which is initially found located on the mem-
brane of red blood cells [5, 24, 31). It is well known 
that Band-3 protein is a 911 amino acid protein, and its 
corresponding gene is located on chromosome 17 [67). 
The carboxyl-terminal domain in Band-3 protein is a hy-
drophobic transmembrane domain to serve the anion 
transport by phosphorylation and dephosphorylation 
[20). Searching for Band-3 and related proteins in non-
erythroid cells and other tissue may confirm the concept 
that a defect in cellular oxalate transport is the funda-
mental abnormality in idiopathic calcium oxalate nephro-
lithiasis. Once it is identified that the defect of oxalate 
transport in the kidney and the gut is similar to that in 
red blood cells, a logical speculation can be made that if 
there is something wrong with Band-3 in red blood cell 
it will be the same for other anion exchangers. Increas-
ing evidence indicates that many anion-exchangers share 
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Figure 3. Anion ex-
changers in cell mem-
branes (both basolateral 
and apical) of renal 
proximal tubular cells. 
Circles with shadow 
represent the ex-
changers relating to 
oxalate transport in 
which a Cr:oxalate 
exchanger and a pos-
sible Na-dependent 
sulphate exchanger at 
the luminal membrane 
surface and a 
so=(oxalate): Hco3-







functional similarities with Band-3 protein. Selected 
Band-3 proteins related to anion transporters of renal 
epithelia are listed by Alper [l] in which MCT (medul-
lary collecting tubule), CCT (cortical collecting tubule), 
CTALH (cortical thick ascending limb of Henle), 
MTALH (medullary thick ascending limb of Henle), PST 
(proximal straight tubule), PT (proximal tubule), BBMV 
(brush border membrane vesicles of proximal tubule), 
and BLMV (basolateral membrane vesicles of proximal 
tubule), LLC-PK I and MDCK are involved. A supposed 
mechanism of oxalate secretion by the renal proximal 
renal tubule is illustrated in Figure 3 [ 46] which has 
recently been confirmed by the new result obtained from 
LLC-PKl cell line [70]. 
Although human erythrocyte Band-3 is encoded by 
a single-copy gene [67], and is expressed only by eryth-
rocytes and by a subpopulation of acid-secreting cells in 
the distal nephron [35] where no oxalate transport oc-
curs, immunological evidence indicates that the genes 
encoding Band-3 protein of the kidney and the intestine 
belong to the same family. Anion exchange in non-
erythroid cells may be mediated by closely related 
molecules. 
In our stone research laboratory, a new cell cul-
ture model has been set up for studying epithelial handl-
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stone salts. In the model system, renal epithelial cells 
cultured in two-compartment Transwell cell culture 
chambers on collagen-coated permeable supports form 
highly differentiated polarized monolayers resembling 
naturally occurring epithelium. Our preliminary result 
did not demonstrate a significant transcellular transport 
in LLC-PKl cell line under the physiological conditions 
used [ 120]. However, oxalate transport across the same 
monolayer of renal proximal tubular epithelial cells 
(LLC-PKl) as we used, has been shown by several re-
search groups [70, 122]. This phenomenon may have 
something to do with the following points: (a) The char-
acteristics of anion transport in LLC-PK 1 cells may have 
been lost; (b) extracellular environment including used 
buffers, temperature, pH and concentration of chloride, 
sulphate and bicarbonate; (c) the state of LLC-PKl cells 
in these experiments; and (d) individual operation pro-
gram in these experiments. We are now trying to search 
for cellular oxalate transport in a primary cultures of 
human renal proximal tubule in our cell culture model. 
We believe that a molecular biological approach 
will provide a powerful complement to immunological 
and ligand-based methods for describing a class of the 
anion transport proteins of renal and other epithelia, 
which would be useful for stone prevention. 
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Oxalate degrading enzymes 
The concept that urinary oxalate is the most im-
portant risk factor in patients with calcium oxalate uro-
lithiasis has been generally accepted. Thus, a logical 
topic for stone research should be to develop effective 
and safe methods for lowering urinary oxalate, regard-
less of the specific aetiology of stone disease. Many 
approaches which may lower urinary oxalate include in-
hibiting oxalate synthesis in liver and kidney, blocking 
oxalate secretion into the renal proximal tubule, and de-
creasing its absorption in the gut. Allison [2] has put 
forward the idea that urinary oxalate may be lowered by 
using oxalate-degrading enzymes in the gut. This sug-
gestion is based on the fact that sheep fed with oxalate-
rich plants, in presence of sufficient numbers of degrad-
ing oxalate bacteria in their rumen (e.g., Oxalobacter 
formigenes) are able to tolerate increased amounts of 
oxalate without forming calcium oxalate stones. 
Although mammalian cells do not produce any en-
zymes that are capable of degrading oxalate, two major 
pathways for the degradation of oxalate in non-mamma-
lian systems are: oxalate oxidase (EC 1.2.3.4) and 
oxalate decarboxylase (EC 4.1.1.2). Recently two coen-
zymes (formyl-CoA-transferase (EC 2.8.3.4) and 
Oxalyl-CoA-decarboxylase (EC 4.1.1. 8) participating in 
biochemical pathways of oxalate degradation in oxalo-
bacter have been purified and identified [9, 10]. It is 
obvious that the applications of these enzymes may con-
tribute towards reducing the circulating oxalate levels in 
vivo. Such treatment could be beneficial for prevention 
of calcium oxalate stone disease. An early example of 
application of oxalate degrading enzyme in vivo has been 
reported by Raghavan and Tarachand [92], who gave 
rats oxalate oxidase plus peroxidase, loaded in dialysis 
membranes, by intraperitoneal implantation. In recent 
years, rapid developments of drug delivering techniques 
such as liposome formation, erythrocyte loading or con-
jugating with poly ethylene glycol (PEG), can be expect-
ed for the therapy of these oxalate-degrading enzymes. 
Based on modern molecular biological concepts, an inno-
vative proposal to transfer the gene of an oxalate-de-
grading enzyme into human cells has been put forward. 
This might be an extremely effective procedure for re-
ducing the amount of oxalate in the body and in urine 
but it is a difficult and dangerous technique. Recently, 
cloning of the oxalyl-CoA decarboxylase gene from the 
bacterium Oxalobacter formigenes and its subsequent ex-
pression in a foreign environment has been demonstrated 
by Lung et al. [66]. 
Concerning the correlation of abnormal macro-
molecular substances (MMS) to urolithiasis, in general, 
isolation, purification and identification of the MMS is 
an important topic in the field of stone research. 
Searching for exact defects of the MMS in stone formers 
could be the first step to understanding the mechanisms 
of stone formation. In addition, it should not be forgot-
ten that existing state of the MMS isolated and their 




In summary, the clinical treatment of urolithiasis 
is still unsatisfactory, in spite of the technological ad-
vances brought by extracorporeal shock wave lithotripsy 
(ESWL) and endoscopic surgery. But why has so little 
progress been achieved in the field of stone prevention? 
Perhaps, the old concepts on stone-formation need to be 
challenged and a fresh approach to the problem intro-
duced. In this paper, we have attempted to do this by 
considering stone-formations a form of bio-mineraliza-
tion subject to the laws of non-equilibrium thermody-
namics and systems science. We firmly believe that the 
processes involved in the formation of stones need to be 
studied at the molecular and cellular level and that there 
needs to be a strengthening of the links between basic 
and clinical research in the field. 
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Discussion with Reviewers 
H.-G. Tiselius: Oxalate is undoubtedly a very powerful 
urinary constitute in terms of calcium oxalate crystalli-
zation. Which limit of normal oxalate excretion is ap-
plied by the authors and according to your experience 
how great is the fraction of stone formers that demon-
strate a hyperoxaluria? 
Authors: According to the critical value for defining 
hyperoxaluria ( > 0.45 mmol of oxalate excreted within 
24-hour urine), approximately 20-25 per cent of the pa-
tients with calcium urolithiasis were found as hyperoxal-
uria in our hospital. Due to the limitation of precise 
analytical methods of oxalate in urine and serum/plasm, 
no systematic metabolic evaluation of hyperoxaluria has 
carried out in our hospital so far. Therefore, we just 
follow the common formula to treatment of the stone pa-
tients with hyperoxaluria. However, we would like to 
emphasize here the following points: 
(a). A systematic evaluation for hyperoxaluria, 
for instance, as Hatch recently described (Urol Res 21: 
55-59, 1993), is clearly needed not only for further un-
derstanding the pathophysiological of hyperoxaluria, but 
also for successful treatment. 
(b). Although many methods to reduce urinary 
oxalate can be chosen as listed in your review (Mineral 
Electrolyte Metab 13: 242-250, 1987), best treatment for 
individual patients with hyperoxaluria should be in ac-
cordance with the classification of hyperoxaluria. Re-
cently, a new classification of hyperoxaluria has been re-
ported in which the term "mild metabolic hyperoxaluria" 
was much improved (Urol Res 21: 55-59, 1993). 
(c). Endogenous production of oxalate contrib-
utes to the hyperoxaluria, therefore, finding a way that 
could significantly reduce endogenous production of 
oxalate may an important topic. 
(d). A link between hyperoxaluria and its molec-
ular and cellular basis should be made in further 
research. 
(e). The viewpoint of system science described in 
the present review paper is certainly needed in the re-
search on hyperoxaluria. For example, Prof. Dr. Rose 
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recently showed that excreted oxalate in plasma and 24-
hour urine significantly decreases with oral pyridoxine 
in normal subjects, but does not in idiopathic stone for-
mers with hyperoxaluria (Urol Res 18: 393-396, 1990). 
This result may reveal a disturbance of system regulation 
existing in patients which could be connected to a injury/ 
dysfunction of renal tubular cells. 
H.-G. Tiselius: Although most calcium stones contain 
calcium oxalate, a significant number of these stones 
also contain calcium phosphate. Do you have any specu-
lation on the role the latter salt plays in these stones? 
Authors: This is an interesting question, and also dif-
ficult to be answered in a brief way. The concept that 
urolithiasis is a heterogeneous disorder, with varying 
chemical composition and pathophysiologic background 
has generally been accepted. Therefore, It is no surprise 
to see the phenomenon that calcium phosphate can often 
be found in calcium oxalate stones. The following spec-
ulations are listed for discussion: 
(a). According to chemical characteristics of the 
calcium ion, calcium is one of the most active and rich 
divalent elements in vivo which can easily form insulated 
salts either in physiological bio-mineralization (e.g., 
bone, teeth and other hard tissues) or in numerous patho-
logical bio-mineralizations (e.g., urinary tract stones and 
dentinal stones). Calcium ions can easily connect to ox-
ygen atoms proved by a number of amino acids of pro-
tein, phosphoproteins and phospholipids. In addition, 
calcium ions can combine with polysaccharides and gly-
coprotein to form stable macromolecules. All those 
macromolecules containing calcium have biochemical 
and physiological activity and certain functions in vivo. 
(b). From the urinary chemistry, human urine is 
supersaturated for a number of calcium phosphates in-
cluding hydroxy apatite (HAP), octacalcium phosphate 
(OCP), and di-calcium phosphate dihydrate (DCPD). 
(c). From the physicochemical viewpoint of stone 
formation, it is well known that calcium oxalate mono-
hydrate (COM) can precipitate on the surface of seed 
crystal of DCPD and HAP and that calcium oxalate tri-
hydrate (COT) can induce crystallization of HAP at low 
levels of supersaturation and HAP was a suitable seed 
for further COM grow. In addition, stone matrix made 
by dysfunctional renal tubular cells can combine with 
HAP as a HAP-sphere that can induce COM heterogene-
ous nucleation. 
(d). From the viewpoint of crystal retention, i.e., 
the interaction between cell and crystal, glycoprotein, an 
important component of the cellular membrane, presum-
ably has only two kinds of binding sites for accepting 
calcium or phosphate, but none for oxalate. Oxalate 
presumably combines with the glycoprotein through a 
phosphate bridge. In addition, phosphoproteins and 
phospholipids located on renal tubular cellular mem-
branes may provide the sites for combining calcium 
which means these macromolecules provide a connection 
between a crystal/stone and tissue. 
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The differences of chemical composition and 
structures shown in a giving stone may have something 
to do with the kinetic process of its formation and with 
disturbances of the patient with urolithiasis. Therefore, 
studying stone composition and structure may be benefi-
cial for understanding the mechanisms of stone forma-
tion. 
H.-G. Tiselius: It is an interesting idea that crystals 
form within the cell, from which they subsequently are 
expelled or released. Would you consider it reasonable 
to assume such a mechanism even for the crystalluria ob-
served in normal subjects. 
Authors: Recently the finding of intracellular crystals 
has been shown in an ultrastructural study of experimen-
tally induced microliths in rat proximal and distal tubu-
les (J Urol 149: 893-899, 1993). Our results strongly 
suggest that renal tubular cells are the host in stone 
formation as a pathological bio-mineralization which 
should be responsible for all earlier events of nephro-
lithiasis. However, it remains uncertain which process 
is the first: luminal crystals or intracellular crystals? 
intracellular changes or intraeellular crystals? There-
fore, at this moment we can hardly imagine the behavior 
of intracellular crystals such as their expelling or 
releasing. 
From the viewpoint of systems science and bio-
mineralization, the crystalluria observed in normal sub-
jects can be thought of as the result of a physiological 
regulation against interference with an excess high con-
centration of stone salts in the urinary system. Crys-
talluria seen in normal subjects also reflects injury/dys-
function of the renal tubular cells, whereas a series of 
abnormalities including renal handling ions, renal secre-
tion modifiers of crystallization and epithelium proper-
ties will happen resulting in stone formation. Therefore, 
crystalluria can be considered as a mirror of the environ-
ment where crystals and stones are formed. 
J.P. Kavanagh: Has the use of system science given 
you new insights into problems of urolithiasis and do 
you think it will help in the future as greater under-
standing of stone formation at the molecular level 
develops? 
Authors: The answer should be "yes". This review 
paper represents our own thinking on current stone re-
search. System science as a tool and a strategy in 
urolithiasis research has been introduced by Prof. 
Finlayson about 20 years ago [41]. In fact, many ap-
plied methods and achieved results in stone research are 
more or less connected with the theory. You yourself 
have also applied this viewpoint to explain the high 
crystal nucleation rate you found in normal subjects 
[57]. Each investigator should have the systematic view-
point when he performs his study. Many examples have 
been presented in our manuscript above. 
